Quantcast

Latest Bayer AG Stories

2014-03-03 04:22:41

TARRYTOWN, N.Y., March 3, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA(®) (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare (MHLW). "Clinically significant DME is a leading cause of vision loss in the working-age...

2014-02-27 16:27:51

Bayer travels to San Antonio for its fourth tour stop to continue promoting bee health across the country at top agriculture universities and events SAN ANTONIO, Feb. 27, 2014 /PRNewswire/ -- In an effort to further education and collaboration around pollinator health, Bayer CropScience will continue its second annual Bee Care Tour with a stop in San Antonio, Texas at Commodity Classic from Feb. 27 - March 1. The mobile tour is traveling coast-to-coast to create awareness of the vital role...

2014-02-27 12:24:04

LONDON, Feb. 27, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Global Adhesives and Sealants Market 2012-2016 TechNavio's analysts forecast the Global Adhesives and Sealants market to grow at a CAGR of 3.86 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in R&D investment and activities. The Global Adhesives and Sealants market has also been witnessing an increasing demand from...

2014-02-26 16:26:01

DUBLIN, February 26, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/khhjl8/erectile) has announced the addition of the "Erectile Dysfunction Drugs Market - Forecast to 2019" [http://www.researchandmarkets.com/research/khhjl8/erectile ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The erectile dysfunction drugs market is expected to witness a decline across the globe, by the end of the...

2014-02-24 08:27:50

TARRYTOWN, N.Y., Feb. 24, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review the Company's supplemental Biologics License Application (sBLA) for EYLEA(®) (aflibercept) Injection for the treatment of Macular Edema following Branch Retinal Vein Occlusion (BRVO). Under the Prescription Drug User Fee Act (PDUFA), the goal for a standard review of an sBLA is ten months from...

2014-02-20 16:27:10

Bayer hit the road to promote bee health by continuing its Tour across the country at top agriculture universities and Commodity Classic CORVALLIS, Ore., Feb. 20, 2014 /PRNewswire/ -- Bayer CropScience continued its second annual Bee Care Tour, a mobile tour designed to emphasize the important role bees play, by making its third stop at Oregon State University in Corvallis. The Tour aims to facilitate education and collaboration among growers, beekeepers and researchers to promote best...

2014-02-17 23:01:47

Bayer continues its tour to promote bee health across the country at top agriculture universities and Commodity Classic. Davis, CA (PRWEB) February 17, 2014 Bayer CropScience continued its second annual Bee Care Tour, a mobile tour designed to emphasize the important role bees play, last week in Davis, Calif. The Tour included an interactive exhibit with two frames of honey in a mobile hive, stewardship workshops and an expert presentation and panel discussion on issues impacting...

2014-02-11 16:26:04

WHIPPANY, N.J., Feb. 11, 2014 /PRNewswire/ -- Bayer HealthCare today issued the following press statement from Dr. Irene Laurora, Vice President, US Medical Affairs, following a joint meeting of the Arthritis Advisory Committee (AAC) and Drug Safety Committee and Risk Management Advisory Committee (DSaRM) on February 10-11, 2014. The joint Advisory Committee panel reviewed the data and analyses published since the last non-steroidal anti-inflammatory drug (NSAID) panel review in 2005...

2014-02-10 23:02:04

Bayer CropScience hits the road to promote bee health by kicking off its Tour across the country at top agriculture universities and Commodity Classic. PULLMAN, Wash. (PRWEB) February 10, 2014 Bayer CropScience launched its second annual Bee Care Tour, a mobile tour designed to emphasize the important role bees play, last week in Pullman, Wash. The Tour included an interactive exhibit with two frames of honey in a mobile hive, stewardship workshops and expert presentations on issues...

2014-02-10 08:26:04

TARRYTOWN, N.Y., Feb. 10, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that in the Phase 3 VISTA-DME trial of EYLEA(®) (aflibercept) Injection for the treatment of diabetic macular edema (DME), EYLEA 2 milligrams (mg) dosed monthly (2Q4) and EYLEA 2 mg dosed every two months (after 5 initial monthly injections, 2Q8) showed a sustained improvement from baseline in best corrected visual acuity (BCVA) at week 100, compared to...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related